Board Members: Bill Ericson
Initiatives: Life Sciences
Ticker: Acquired by Affymetrix

Revealing Genetic Variations
ParAllele BioScience accelerated healthcare breakthroughs by providing comprehensive genetic discovery solutions to the life science research, pharmaceutical and diagnostic sectors. The company's products and services utilized a unique approach that leveraged novel biochemical processes rather than complex instrumentation to discover and analyze minute variations in the human genome. The understanding of how subtle genetic variations contribute to disease risk, prognosis and drug response helps lead to new and more effective drugs, predictive diagnosis, and the ability to better tailor therapies to individual patients.